This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/14/2024
Operator
Conference Operator
Good morning and welcome to Trisalis Life Sciences third quarter 2024 earnings conference call. Currently, all participants are in a listen-only mode. We will facilitate a question and answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host, Jim Young, Senior Vice President of Investor Relations and Treasurer at Trisalis, for a few introductory comments.
Jim Young
Senior Vice President of Investor Relations and Treasurer
Thank you all for participating in today's call.
Jim Young
Senior Vice President of Investor Relations and Treasurer
Joining me today from Trisalis Life Sciences are Mary Zella, President and Chief Executive Officer, and Sean Murphy, Chief Financial Officer. Earlier this morning, Trisalis released financial results for the third quarter ended September 30, 2024. A copy of the press release is available on Trisalis' website. Before we begin, I would like to remind you that we will be making forward-looking statements based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please see the risk factors in our SEC filings for additional details. And with that, I'll turn the call over to Mary.
You're reading a preview of the TLSI Q3 2024 earnings call.
Free account.
Disclaimer